TGFB1 and hypersensitivity reaction disease: Conversely, ASP/OVA-mediated allergic sensitization, which does not trigger acute neutrophilia or lead to immunosuppression of established inflammation (Figure 1, B and C), failed to elicit TGF-β production (Figure 6F).